TY  - JOUR

T1  - Clinically meaningful responses to dupilumab among children aged 6 months to 5 years with moderate-to-severe atopic dermatitis who did not achieve clear or almost clear skin according to the investigator’s global assessment: a post hoc analysis of a phase 3 trial

JO  - Acta Dermato-Venereologica

UR  - https://eprints.whiterose.ac.uk/id/eprint/210757

PY  - 2024/02/12

AU  - Cork MJ

AU  - Lockshin B

AU  - Pinter A

AU  - Chen Z

AU  - Shumel B

AU  - Prescilla R

ED  - 

DO  - DOI: 10.2340/actadv.v104.13467

PB  - MJS Publishing, Medical Journals Sweden AB

VL  - 104

Y2  - 2025/11/05

ER  -